Open Access

Association of nutraceutical supplements with longer telomere length

  • Authors:
    • Dimitris Tsoukalas
    • Persefoni Fragkiadaki
    • Anca Oana Docea
    • Athanasios K. Alegakis
    • Evangelia Sarandi
    • Elena Vakonaki
    • Eralda Salataj
    • Elisavet Kouvidi
    • Dragana Nikitovic
    • Leda Kovatsi
    • Demetrios A. Spandidos
    • Aristidis Tsatsakis
    • Daniela Calina
  • View Affiliations

  • Published online on: May 10, 2019     https://doi.org/10.3892/ijmm.2019.4191
  • Pages: 218-226
  • Copyright: © Tsoukalas et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Telomeres are nucleotide tandem repeats located at the tip of eukaryotic chromosomes that maintain genomic integrity. The gradual shortening of telomeres leads to cellular senescence and apoptosis, a key mechanism of aging and age‑related chronic diseases. Epigenetic factors, such as nutrition, exercise and tobacco can affect the rate at which telomeres shorten and can modify the risk of developing chronic diseases. In this study, we evaluated the effects of a combination of nutraceutical supplements (NS) on telomere length (TL) in healthy volunteers with no medical history of any disease. Participants (n=47) were selected from healthy outpatients visiting a private clinic and were divided into the experimental group (n=16), that received the NS and the control group (n=31). We estimated the length of single telomeres in metaphase spread leukocytes, isolated from peripheral blood, using quantitative‑fluorescent in situ hybridization (Q‑FISH) analysis. The length of the whole telomere genome was significantly increased (P<0.05) for the mean, 1st quartile and median measurements in the experimental group. Similar findings were observed for short TL (20th percentile) (P<0.05) for the median and 3rd quartile measurements in the NS group, compared to the control group. The beneficial effects of the supplements on the length of short telomeres remained significant (P<0.05) following adjustment for age and sex. Telomeres were moderately longer in female patients compared to the male patients. On the whole, the findings of this study suggest that the administration of NS may be linked to sustaining the TL.

References

1 

Starkweather AR, Alhaeeri AA, Montpetit A, Brumelle J, Filler K, Montpetit M, Mohanraj L, Lyon DE and Jackson-Cook CK: An integrative review of factors associated with telomere length and implications for biobehavioral research. Nurs Res. 63. pp. 36–50. 2014, View Article : Google Scholar

2 

Blackburn EH, Chan S, Chang J, Fulton TB, Krauskopf A, McEachern M, Prescott J, Roy J, Smith C and Wang H: Molecular manifestations and molecular determinants of telomere capping. Cold Spring Harb Symp Quant Biol. 65:253–263. 2000. View Article : Google Scholar

3 

Beyne-Rauzy O, Prade-Houdellier N, Demur C, Recher C, Ayel J, Laurent G and Mansat-De Mas V: Tumor necrosis factor- alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells. Blood. 106:3200–3205. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Westin ER, Aykin-Burns N, Buckingham EM, Spitz DR, Goldman FD and Klingelhutz AJ: The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency. Antioxid Redox Signal. 14:985–997. 2011. View Article : Google Scholar :

5 

Fragkiadaki P, Tsoukalas D, Fragkiadoulaki I, Psycharakis C, Nikitovic D, Spandidos DA and Tsatsakis AM: Telomerase activity in pregnancy complications (Review). Mol Med Rep. 14:16–21. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Fujii H, Shao L, Colmegna I, Goronzy JJ and Weyand CM: Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA. 106:4360–4365. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Vakonaki E, Tsiminikaki K, Plaitis S, Fragkiadaki P, Tsoukalas D, Katsikantami I, Vaki G, Tzatzarakis MN, Spandidos DA and Tsatsakis AM: Common mental disorders and association with telomere length. Biomed Rep. 8:111–116. 2018.PubMed/NCBI

8 

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK and Spitz MR: Telomere dysfunction: A potential cancer predisposition factor. J Natl Cancer Inst. 95. pp. 1211–1218. 2003, View Article : Google Scholar

9 

Willeit P, Raschenberger J, Heydon EE, Tsimikas S, Haun M, Mayr A, Weger S, Witztum JL, Butterworth AS, Willeit J, et al: Leucocyte telomere length and risk of type 2 diabetes mellitus: New prospective cohort study and literature-based meta-analysis. PLoS One. 9:e112483. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Calado RT and Young NS: Telomere diseases. N Engl J Med. 361:2353–2365. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Turner KJ, Vasu V and Griffin DK: Telomere biology and human phenotype. Cells. 8:E732019. View Article : Google Scholar : PubMed/NCBI

12 

Sanders JL and Newman AB: Telomere length in epidemiology: A biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 35:112–131. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Vera E, Bernardes de Jesus B, Foronda M, Flores JM and Blasco MA: The rate of increase of short telomeres predicts longevity in mammals. Cell Rep. 2:732–737. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Vakonaki E, Tzatzarakis M, Tsiminikaki K, Nathena D, Fragkiadaki P, Kalliantasi K, Kanaki K, Vaki G, Plaitis S, Tsoukalas D, et al: Effect of chronic and heavy drug abuse on biological aging. World Acad Sci. 1:67–73. 2019.

15 

Tsatsakis A, Tsoukalas D, Fragkiadaki P, Vakonaki E, Tzatzarakis M, Sarandi E, Nikitovic D, Tsilimidos G and Alegakis AK: Developing BIOTEL: A semi-automated spreadsheet for estimating telomere length and biological age. Front Genet. 10:842019. View Article : Google Scholar : PubMed/NCBI

16 

Shay JW and Wright WE: Hallmarks of telomeres in ageing research. J Pathol. 211:114–123. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Muraki K, Nyhan K, Han L and Murnane JP: Mechanisms of telomere loss and their consequences for chromosome instability. Front Oncol. 2:1352012. View Article : Google Scholar : PubMed/NCBI

18 

Hemann MT, Strong MA, Hao LY and Greider CW: The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 107:67–77. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Hao LY, Armanios M, Strong MA, Karim B, Feldser DM, Huso D and Greider CW: Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell. 123:1121–1131. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Baltzis D, Meimeti E, Grammatikopoulou MG, Roustit M, Mavrogonatou E, Kletsas D, Efraimidou S, Manes C, Nikolouzakis TK, Tsiaoussis J, et al: Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters. Exp Ther Med. 15:3420–3424. 2018.PubMed/NCBI

21 

Nikolouzakis TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, Papadakis GZ, Spandidos DA, Tsatsakis AM and Tsiaoussis J: Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review). Oncol Rep. 39:2455–2472. 2018.PubMed/NCBI

22 

Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A and Willeit P: Leucocyte telomere length and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ. 349. pp. g42272014, View Article : Google Scholar

23 

Goglin SE, Farzaneh-Far R, Epel ES, Lin J, Blackburn EH and Whooley MA: Change in leukocyte telomere length predicts mortality in patients with stable coronary heart; disease from the heart and soul study. PLoS One. 11:e01607482016. View Article : Google Scholar

24 

De Meyer T, Vandepitte K, Denil S, De Buyzere ML, Rietzschel ER and Bekaert S: A non-genetic, epigenetic-like mechanism of telomere length inheritance? Eur J Hum Genet. 22:10–11. 2014. View Article : Google Scholar

25 

Armanios M: Telomeres and age-related disease: How telomere biology informs clinical paradigms. J Clin Invest. 123:996–1002. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Pusceddu I, Herrmann M, Kirsch SH, Werner C, Hübner U, Bodis M, Laufs U, Wagenpfeil S, Geisel J and Herrmann W: Prospective study of telomere length and LINE-1 methylation in peripheral blood cells: The role of B vitamins supplementation. Eur J Nutr. 55:1863–1873. 2016. View Article : Google Scholar

27 

Pusceddu I, Herrmann M, Kirsch SH, Werner C, Hübner U, Bodis M, Laufs U, Widmann T, Wagenpfeil S, Geisel J, et al: One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation. Eur J Nutr. 56:1887–1898. 2017. View Article : Google Scholar

28 

Richards JB, Valdes AM, Gardner JP, Paximadas D, Kimura M, Nessa A, Lu X, Surdulescu GL, Swaminathan R, Spector TD, et al: Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr. 86:1420–1425. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Moores CJ, Fenech M and O'Callaghan NJ: Telomere dynamics: The influence of folate and DNA methylation. Ann NY Acad Sci. 1229:76–88. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Holick MF: Vitamin D deficiency. N Engl J Med. 357:266–281. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Nazki FH, Sameer AS and Ganaie BA: Folate: Metabolism, genes, polymorphisms and the associated diseases. Gene. 533:11–20. 2014. View Article : Google Scholar

32 

Barden A, O'Callaghan N, Burke V, Mas E, Beilin LJ, Fenech M, Irish AB, Watts GF, Puddey IB, Huang RC, et al: n-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease. Nutrients. 8:1752016. View Article : Google Scholar : PubMed/NCBI

33 

Calder PC: Polyunsaturated fatty acids and inflammation. Biochem Soc Trans. 33:423–427. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB and Glaser R: Omega- 3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain Behav Immun. 25:1725–1734. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Nälsén C, Vessby B, Berglund L, Uusitupa M, Hermansen K, Riccardi G, Rivellese A, Storlien L, Erkkilä A, Ylä-Herttuala S, et al: Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr. 136:1222–1228. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Zhang J, Rane G, Dai X, Shanmugam MK, Arfuso F, Samy RP, Lai MK, Kappei D, Kumar AP and Sethi G: Ageing and the telomere connection: An intimate relationship with inflammation. Ageing Res Rev. 25:55–69. 2016. View Article : Google Scholar

37 

Shen J, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI and Santella RM: Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer. 124:1637–1643. 2009. View Article : Google Scholar :

38 

Furumoto K, Inoue E, Nagao N, Hiyama E and Miwa N: Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci. 63:935–948. 1998. View Article : Google Scholar : PubMed/NCBI

39 

Yokoo S, Furumoto K, Hiyama E and Miwa N: Slow- down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress. J Cell Biochem. 93:588–597. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Kashino G, Kodama S, Nakayama Y, Suzuki K, Fukase K, Goto M and Watanabe M: Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. Free Radic Biol Med. 35:438–443. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Tanaka Y, Moritoh Y and Miwa N: Age- dependent telomere- shortening is repressed by phosphorylated alpha-tocopherol together with cellular longevity and intracellular oxidative-stress reduction in human brain microvascular endotheliocytes. J Cell Biochem. 102:689–703. 2007. View Article : Google Scholar : PubMed/NCBI

42 

Tsoukalas D, Fragkiadaki P, Docea AO, Alegakis AK, Sarandi E, Spandidos DA, Tsatsakis A, Razgonova MP and Calina D: Discovering novel telomerase activators. Mol Med Rep. In press.

43 

Bailey RL, West KP Jr and Black RE: The epidemiology of global micronutrient deficiencies. Ann Nutr Metab. 66(Suppl 2): 22–33. 2015. View Article : Google Scholar : PubMed/NCBI

44 

Fairfield KM and Fletcher RH: Vitamins for chronic disease prevention in adults: Scientific review. JAMA. 287:3116–3126. 2002. View Article : Google Scholar : PubMed/NCBI

45 

McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, Szumiel I, Bryant PE, Riches AC, Thompson A, Blasco MA, et al: Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61:912–915. 2001.PubMed/NCBI

46 

Lindqvist D, Epel ES, Mellon SH, Penninx BW, Révész D, Verhoeven JE, Reus VI, Lin J, Mahan L, Hough CM, et al: Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev. 55:333–364. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Masi S, Salpea KD, Li K, Parkar M, Nibali L, Donos N, Patel K, Taddei S, Deanfield JE, D'Aiuto F, et al: Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis. Free Radic Biol Med. 50:730–735. 2011. View Article : Google Scholar : PubMed/NCBI

48 

Watfa G, Dragonas C, Brosche T, Dittrich R, Sieber CC, Alecu C, Benetos A and Nzietchueng R: Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. J Nutr Health Aging. 15:277–281. 2011. View Article : Google Scholar : PubMed/NCBI

49 

Ma D, Zhu W, Hu S, Yu X and Yang Y: Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients. J Endocrinol Invest. 36:1032–1037. 2013.PubMed/NCBI

50 

de Vos-Houben JM, Ottenheim NR, Kafatos A, Buijsse B, Hageman GJ, Kromhout D and Giltay EJ: Telomere length, oxidative stress, and antioxidant status in elderly men in Zutphen and Crete. Mech Ageing Dev. 133:373–377. 2012. View Article : Google Scholar : PubMed/NCBI

51 

Prasad KN, Wu M and Bondy SC: Telomere shortening during aging: Attenuation by antioxidants and anti- inflammatory agents. Mech Ageing Dev. 164:61–66. 2017. View Article : Google Scholar : PubMed/NCBI

52 

Paul L: Diet, nutrition and telomere length. J Nutr Biochem. 22:895–901. 2011. View Article : Google Scholar : PubMed/NCBI

53 

Herrmann M, Pusceddu I, Marz W and Herrmann W: Telomere biology and age- related diseases. Clin Chem Lab Med. 56:1210–1222. 2018. View Article : Google Scholar : PubMed/NCBI

54 

Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, Malarkey WB, Hwang BS and Blackburn E: Omega- 3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. Brain Behav Immun. 28:16–24. 2013. View Article : Google Scholar

Related Articles

Journal Cover

July 2019
Volume 44 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Tsoukalas, D., Fragkiadaki, P., Docea, A.O., Alegakis, A.K., Sarandi, E., Vakonaki, E. ... Calina, D. (2019). Association of nutraceutical supplements with longer telomere length. International Journal of Molecular Medicine, 44, 218-226. https://doi.org/10.3892/ijmm.2019.4191
MLA
Tsoukalas, D., Fragkiadaki, P., Docea, A. O., Alegakis, A. K., Sarandi, E., Vakonaki, E., Salataj, E., Kouvidi, E., Nikitovic, D., Kovatsi, L., Spandidos, D. A., Tsatsakis, A., Calina, D."Association of nutraceutical supplements with longer telomere length". International Journal of Molecular Medicine 44.1 (2019): 218-226.
Chicago
Tsoukalas, D., Fragkiadaki, P., Docea, A. O., Alegakis, A. K., Sarandi, E., Vakonaki, E., Salataj, E., Kouvidi, E., Nikitovic, D., Kovatsi, L., Spandidos, D. A., Tsatsakis, A., Calina, D."Association of nutraceutical supplements with longer telomere length". International Journal of Molecular Medicine 44, no. 1 (2019): 218-226. https://doi.org/10.3892/ijmm.2019.4191